Recommended Topic Related To:

Lialda

"The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.

Simponi works by blocking tumor necrosis factor (TNF), which plays an important"...

Lialda

PATIENT INFORMATION

  • Instruct patients not to take LIALDA if they have hypersensitivity to salicylates (e.g., aspirin) or other mesalamines.
  • Inform patients to let their physicians know all medications they are taking and if they:
    • are allergic to sulfasalazine, salicylates or mesalamine;
    • are taking non-steroidal anti-inflammatory drugs (NSAIDs) or other nephrotoxic agents;
    • are taking azathioprine, or 6-mercaptopurine;
    • experience cramping, abdominal pain, bloody diarrhea, fever, headache or rash;
    • have a history of myocarditis or pericarditis;
    • have kidney or liver disease;
    • have a history of stomach blockage;
    • are pregnant, intend to become pregnant or are breast-feeding.
  • Patients should be instructed to swallow LIALDA delayed-release tablets whole, taking care not to break the outer coating.

Last reviewed on RxList: 1/27/2014
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.